Diphenylcyclopropenone-induced vitiligo in a patient with alopecia universalis.
Case Rep Dermatol
; 5(2): 225-31, 2013.
Article
em En
| MEDLINE
| ID: mdl-24019775
ABSTRACT
Alopecia areata and vitiligo are autoimmune diseases, both associated with multiple autoimmune comorbidities. Many studies show colocalization of these diseases at the same anatomical site. Here, we have a case where both disorders were reported to present in the same patient. Diphenylcyclopropenone (diphencyprone, DCP) is used in the treatment of alopecia areata and may induce vitiligo in some patients. We report on one case of vitiligo that was induced by DCP during therapy for alopecia universalis. Alopecia areata and vitiligo share many susceptibility genes. Follicular melanocyte destruction may represent the link between the two diseases.
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Idioma:
En
Revista:
Case Rep Dermatol
Ano de publicação:
2013
Tipo de documento:
Article
País de afiliação:
Qatar